Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00232128
Other study ID # CCI LUN 02
Secondary ID
Status Terminated
Phase N/A
First received October 3, 2005
Last updated January 11, 2007
Start date June 2003

Study information

Verified date May 2006
Source Oncology Specialties, Alabama
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.


Recruitment information / eligibility

Status Terminated
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 19 Years and older
Eligibility Inclusion Criteria: The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following:

1. unresectable primary or metastatic lung tumors

2. may benefit from multiple modalities of therapy

3. chemotherapeutic or radiation oncologic options have been exhausted

Exclusion Criteria:

1. co-existing morbidities that preclude the use of surgery

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Radiofrequency Ablation of pulmonary neoplasms


Locations

Country Name City State
United States Comprehensive Cancer Institute Huntsville Alabama

Sponsors (1)

Lead Sponsor Collaborator
Oncology Specialties, Alabama

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Completed NCT05011890 - Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® N/A
Completed NCT00132639 - Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) Phase 2
Completed NCT00290953 - Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide Phase 2/Phase 3
Terminated NCT00241267 - Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease N/A
Terminated NCT02673021 - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) N/A
Completed NCT00042679 - A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. Phase 2
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A
Recruiting NCT04699188 - Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Phase 1/Phase 2
Completed NCT02410603 - Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Recruiting NCT02549638 - Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Completed NCT02483052 - RejuvenAir Lobectomy for Safety and Histology Phase 1/Phase 2
Completed NCT02370303 - A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Completed NCT01470248 - Study of Arsenic Trioxide in Small Cell Lung Cancer Phase 2
Completed NCT00922155 - Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath N/A